Developer docs
API playgroundTry for free, no card

Search company profiles

Arthrex

Full company profile

uuid0002jiy

Namestring
Arthrex
Legal namestring
Arthrex, Inc.
Websiteurl
arthrex.com
Company typeenum
Private
Founded yearint
1981
Descriptiontext

Arthrex is a privately held global medical device company founded in 1981 and headquartered in Naples, Florida, that designs, manufactures, and sells minimally invasive orthopedic surgical devices, implants, and instruments across eight sub-specialty categories: shoulder, knee, foot and ankle, spine, orthobiologics, hip, trauma, and cardiothoracic surgery. The portfolio includes differentiated proprietary technologies such as the NanoNeedle Scope 2.0 miniaturized arthroscopy system, the DualCompression Hindfoot Nail with a superelastic nitinol core, the TightRope SB all-suture ACL implant, the InternalBrace ligament augmentation technique, and the Synergy OR integration platform, supported by a vertically integrated manufacturing footprint that includes Arthrex Manufacturing Inc. in South Carolina.

The company sells exclusively through a direct enterprise field-sales model of more than 3,800 local representatives serving hospitals, ambulatory surgery centers, and surgeon practices globally, with a dedicated ASC consulting arm (ASC X) that bundles facility design, construction management, and technology integration into the hardware sale. A substantial portion of Arthrex's competitive position is built on its medical-education infrastructure — ArthroLab training facilities, the OrthoPedia platform, 160 regional skill labs, and 100+ annual surgeon courses — anchored by a clinical evidence base of more than 4,000 peer-reviewed publications and 400+ active studies.

Revenue mechanics are anchored in direct quote-based hardware sales of implants and consumables to surgical customers, with no publicly disclosed pricing. The company is independently owned, has no disclosed parent or institutional investors, operates across North America, Latin America, Europe/Middle East/Africa, and Asia Pacific, and runs wholly owned subsidiaries including Arthrex Vet Systems for veterinary orthopedics and Arthrex Singapore for Asia Pacific operations. Founder Reinhold D. Schmieding continues to serve as founder and CEO.

Short descriptiontext

Arthrex is a privately held global medical device company that designs and sells minimally invasive orthopedic surgical implants and instruments across shoulder, knee, foot/ankle, spine, trauma, and orthobiologics, distributed directly to surgeons, hospitals, and ASCs through 3,800+ field representatives and supported by ArthroLab medical-education infrastructure.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersNaples, United States
HQ citystring
Naples
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
orthopedic medical devices, minimally invasive surgery, arthroscopic implants, sports medicine devices, orthopedic surgical instruments
Industry5 codes
1Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation)
CodeHLAHAEABPrimaryYes
2Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
CodeHLAHAEALPrimaryNo
3Hip & Knee Reconstruction (Arthroplasty)
CodeHLAKALAHPrimaryNo
4Orthopedic & Implantable Devices (Plates, Screws, TPLO, Prosthetics)
CodeHLAMAFAEPrimaryNo
53D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
CodeHLAHAEAJPrimaryNo
NAICS code3 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Surgical and Medical Instrument Manufacturing339112
  • Medical Equipment and Supplies Manufacturing3391
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Orthopedic Medical Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device and Implant Sales
TypeHardware Sales
Description

Sale of orthopedic surgical implants, instruments, and devices including plates, screws, nails, sutures, and soft tissue repair products through direct sales force to hospitals, ASCs, and surgeon practices.

arthrex.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 10 records shown
1ASC X
Description

Ambulatory Surgery Center Innovation program offering partnership and consulting services for outpatient surgery centers

arthrex.com
+9 more records
Core offering1 text field

Arthrex designs, manufactures, and sells orthopedic medical devices, surgical implants, and instruments for minimally invasive procedures across multiple specialties including shoulder, knee, foot and ankle, spine, hip, trauma, cardiothoracic surgery, and orthobiologics. The company supports its product portfolio with comprehensive surgeon medical education through ArthroLab training facilities and the OrthoPedia online platform, and offers ASC X consulting and partnership services to ambulatory surgery centers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 32-day recovery time for elbow surgery using NanoNeedle Scope 2.0 vs typical 2-3 month recovery
+2 more records
Product overview1 text field

Arthrex is a medical device company specializing in minimally invasive orthopedic products and surgical techniques. The portfolio is organized as a comprehensive platform spanning multiple procedure areas: Shoulder (including Eclipse Total Shoulder System, FiberTak anchors, Loop 'N' Tack biceps tenodesis), Knee (MPFL Reconstruction, TightRope SB all-suture implant, InternalBrace), Foot and Ankle (DualCompression Hindfoot Nail, Lapidus I-Beam Plate), Spine (Interlaminar Endoscopic Discectomy, NanoNeedle Scope 2.0), Orthobiologics (AlloSync bone graft solutions), Hip (SutureCast and LoopLoc systems), Trauma (Variable-Angle Proximal Tibial Plating System), and Cardiothoracic Surgery. Supporting infrastructure includes Synergy Solutions for OR integration, ASC X partnership services, ArthroLab training facilities, and OrthoPedia education platform.

Product and service1 record
1Arthrex Shoulder Products
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2026-02-19
Description

Sponsorship to enhance sports medicine education and injury prevention resources for student-athletes, coaches, and trainers in New York. Arthrex provides educational content and access to the ACLTear.com platform focusing on ACL injury prevention, treatment, and recovery.

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Largest pure-play orthopedic medical device competitor with overlapping sports medicine, joint reconstruction, trauma, and surgical instrument portfolios serving the same hospital and ASC customers.

TypeDirect peer
Description

Direct competitor in knee, hip, shoulder, and sports medicine implants and instrumentation with comparable global sales force coverage of orthopedic surgeons.

TypeDirect peer
Description

Broad orthopedics portfolio including sports medicine, trauma, spine, and joint reconstruction, competing head-to-head across most of Arthrex's product categories.

TypeDirect peer
Description

Competing orthopedic device maker with sports medicine, knee/hip reconstruction, and trauma offerings targeting the same surgeon and ASC customer base.

TypeBroad incumbent
Description

Spine and biologics overlap through Medtronic's spine division; broader diversified device giant competing in adjacent orthopedic segments.

TypeDirect peer
Description

Spine-focused orthopedic device competitor with minimally invasive surgical approaches that overlap Arthrex's spine endoscopy portfolio.

TypeDirect peer
Description

Musculoskeletal device company with spine, trauma, and orthobiologics offerings competing for similar surgeon customers and ASC contracts.

TypeDirect peer
Description

Sports medicine and orthopedic surgical device competitor with overlapping arthroscopy, soft tissue repair, and surgical visualization products.

TypeDirect peer
Description

Orthopedics and tissue technologies competitor with sports medicine, extremities, and surgical instrumentation overlap.

TypeEmerging player
Description

Orthobiologics and joint preservation specialist overlapping with Arthrex's AlloSync bone graft and cartilage restoration lines.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Arthrex

Orthopedic Medical Devicesarthrex.com

Arthrex is a privately held global medical device company that designs and sells minimally invasive orthopedic surgical implants and instruments across shoulder, knee, foot/ankle, spine, trauma, and orthobiologics, distributed directly to surgeons, hospitals, and ASCs through 3,800+ field representatives and supported by ArthroLab medical-education infrastructure.

What Arthrex does

Arthrex is a privately held global medical device company founded in 1981 and headquartered in Naples, Florida, that designs, manufactures, and sells minimally invasive orthopedic surgical devices, implants, and instruments across eight sub-specialty categories: shoulder, knee, foot and ankle, spine, orthobiologics, hip, trauma, and cardiothoracic surgery. The portfolio includes differentiated proprietary technologies such as the NanoNeedle Scope 2.0 miniaturized arthroscopy system, the DualCompression Hindfoot Nail with a superelastic nitinol core, the TightRope SB all-suture ACL implant, the InternalBrace ligament augmentation technique, and the Synergy OR integration platform, supported by a vertically integrated manufacturing footprint that includes Arthrex Manufacturing Inc. in South Carolina.

The company sells exclusively through a direct enterprise field-sales model of more than 3,800 local representatives serving hospitals, ambulatory surgery centers, and surgeon practices globally, with a dedicated ASC consulting arm (ASC X) that bundles facility design, construction management, and technology integration into the hardware sale. A substantial portion of Arthrex's competitive position is built on its medical-education infrastructure — ArthroLab training facilities, the OrthoPedia platform, 160 regional skill labs, and 100+ annual surgeon courses — anchored by a clinical evidence base of more than 4,000 peer-reviewed publications and 400+ active studies.

Revenue mechanics are anchored in direct quote-based hardware sales of implants and consumables to surgical customers, with no publicly disclosed pricing. The company is independently owned, has no disclosed parent or institutional investors, operates across North America, Latin America, Europe/Middle East/Africa, and Asia Pacific, and runs wholly owned subsidiaries including Arthrex Vet Systems for veterinary orthopedics and Arthrex Singapore for Asia Pacific operations. Founder Reinhold D. Schmieding continues to serve as founder and CEO.

Arthrex firmographics

Firmographics
Name
Arthrex
Legal name
Arthrex, Inc.
Website
https://arthrex.com
Company type
Private
Founded year
1981
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Arthrex is a privately held global medical device company that designs and sells minimally invasive orthopedic surgical implants and instruments across shoulder, knee, foot/ankle, spine, trauma, and orthobiologics, distributed directly to surgeons, hospitals, and ASCs through 3,800+ field representatives and supported by ArthroLab medical-education infrastructure.
Ownership category
akta.pro rank

Arthrex industry classification

Industry
Product category
Orthopedic Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)
akta.pro secondary industries
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine) (HLAHAEAL), Hip & Knee Reconstruction (Arthroplasty) (HLAKALAH), Orthopedic & Implantable Devices (Plates, Screws, TPLO, Prosthetics) (HLAMAFAE), 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ)

Keywords

  • Orthopedic medical devices
  • Minimally invasive surgery
  • Arthroscopic implants
  • Sports medicine devices
  • Orthopedic surgical instruments

Where Arthrex is headquartered

Location

Headquarters

HQ city
Naples
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Arthrex business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device and Implant Sales: Sale of orthopedic surgical implants, instruments, and devices including plates, screws, nails, sutures, and soft tissue repair products through direct sales force to hospitals, ASCs, and surgeon practices.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Arthrex product offering

Product offering

Core offering

Arthrex designs, manufactures, and sells orthopedic medical devices, surgical implants, and instruments for minimally invasive procedures across multiple specialties including shoulder, knee, foot and ankle, spine, hip, trauma, cardiothoracic surgery, and orthobiologics. The company supports its product portfolio with comprehensive surgeon medical education through ArthroLab training facilities and the OrthoPedia online platform, and offers ASC X consulting and partnership services to ambulatory surgery centers.

Product overview

Arthrex is a medical device company specializing in minimally invasive orthopedic products and surgical techniques. The portfolio is organized as a comprehensive platform spanning multiple procedure areas: Shoulder (including Eclipse Total Shoulder System, FiberTak anchors, Loop 'N' Tack biceps tenodesis), Knee (MPFL Reconstruction, TightRope SB all-suture implant, InternalBrace), Foot and Ankle (DualCompression Hindfoot Nail, Lapidus I-Beam Plate), Spine (Interlaminar Endoscopic Discectomy, NanoNeedle Scope 2.0), Orthobiologics (AlloSync bone graft solutions), Hip (SutureCast and LoopLoc systems), Trauma (Variable-Angle Proximal Tibial Plating System), and Cardiothoracic Surgery. Supporting infrastructure includes Synergy Solutions for OR integration, ASC X partnership services, ArthroLab training facilities, and OrthoPedia education platform.

Differentiator

Problem solved

Functional benefit

Brands

  • ASC X: Ambulatory Surgery Center Innovation program offering partnership and consulting services for outpatient surgery centers
  • Synergy
  • ArthroLab
  • OrthoPedia
  • Studio X
  • NanoNeedle Scope 2.0
  • AlloSync
  • BioSurge
  • TightRope SB
  • InternalBrace

Products and services

  • Arthrex Shoulder Products

Quantifiable outcome

  • 32-day recovery time for elbow surgery using NanoNeedle Scope 2.0 vs typical 2-3 month recovery
  • +2 more outcomes

Companies that use Arthrex

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Arthrex technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Arthrex partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • NYSPHSAA (New York State Public High School Athletic Association)minorGTM or Marketing Partner · 19 February 2026Sponsorship to enhance sports medicine education and injury prevention resources for student-athletes, coaches, and trainers in New York. Arthrex provides educational content and access to the ACLTear.com platform focusing on ACL injury prevention, treatment, and recovery.

Scale indicators7 records

Recent moves2 records

Expansion highlights6 records

Arthrex competitors and assessment

Company assessment

Direct peers

  • Stryker: Largest pure-play orthopedic medical device competitor with overlapping sports medicine, joint reconstruction, trauma, and surgical instrument portfolios serving the same hospital and ASC customers.
  • Zimmer Biomet: Direct competitor in knee, hip, shoulder, and sports medicine implants and instrumentation with comparable global sales force coverage of orthopedic surgeons.
  • Johnson & Johnson (DePuy Synthes): Broad orthopedics portfolio including sports medicine, trauma, spine, and joint reconstruction, competing head-to-head across most of Arthrex's product categories.
  • Smith+Nephew: Competing orthopedic device maker with sports medicine, knee/hip reconstruction, and trauma offerings targeting the same surgeon and ASC customer base.
  • NuVasive: Spine-focused orthopedic device competitor with minimally invasive surgical approaches that overlap Arthrex's spine endoscopy portfolio.
  • Globus Medical: Musculoskeletal device company with spine, trauma, and orthobiologics offerings competing for similar surgeon customers and ASC contracts.
  • CONMED: Sports medicine and orthopedic surgical device competitor with overlapping arthroscopy, soft tissue repair, and surgical visualization products.
  • Integra LifeSciences: Orthopedics and tissue technologies competitor with sports medicine, extremities, and surgical instrumentation overlap.

Broad incumbents

  • Medtronic: Spine and biologics overlap through Medtronic's spine division; broader diversified device giant competing in adjacent orthopedic segments.

Emerging players

  • Anika Therapeutics: Orthobiologics and joint preservation specialist overlapping with Arthrex's AlloSync bone graft and cartilage restoration lines.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Arthrex social profiles

Digital presence

Arthrex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Arthrex leadership team

Management profile

Number of profiles

Profiles1 record

Arthrex subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Arthrex funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Arthrex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arthrex

What does Arthrex do?

Arthrex designs, manufactures, and sells orthopedic medical devices, surgical implants, and instruments for minimally invasive procedures across multiple specialties including shoulder, knee, foot and ankle, spine, hip, trauma, cardiothoracic surgery, and orthobiologics. The company supports its product portfolio with comprehensive surgeon medical education through ArthroLab training facilities and the OrthoPedia online platform, and offers ASC X consulting and partnership services to ambulatory surgery centers.

Is Arthrex a public or private company?

Arthrex is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Arthrex founded?

Arthrex was founded in 1981. It employs 5,001 to 10,000 people.

Where is Arthrex based?

Arthrex is headquartered in Naples, United States, in the North America region.

How does Arthrex make money?

One revenue line is on record: medical Device and Implant Sales.

Who are Arthrex's main competitors?

Direct peers on record are Stryker, Zimmer Biomet, Johnson & Johnson (DePuy Synthes), Smith+Nephew, NuVasive, Globus Medical, CONMED and Integra LifeSciences. Medtronic is listed as a broad incumbent. Anika Therapeutics is listed as an emerging player.

Does Arthrex have an API?

No public API is recorded for Arthrex.

What industry is Arthrex in?

Arthrex's product category is Orthopedic Medical Devices. Its primary akta.pro industry code is HLAHAEAB, Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation), with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireHassan Usmani, D.P.M., Becomes First in the State of Indiana to Use Arthrex Plate and Medial Capsule Repair System for Patients with BunionsOrthopedic surgeon Hassan Usmani at Lakeshore Bone & Joint Institute in Indiana became the first in the state to complete a bunion correction procedure using Arthrex's Lapidus I-Beam Plate and BunionBrace system, performed at Lakeshore Surgicare in Chesterton. The system offers a minimally invasive, joint-preserving option designed to support bone correction and medial capsule stabilization while reducing pain and improving toe alignment. Lakeshore Bone & Joint Institute stated the technology reflects its commitment to integrating advanced orthopedic solutions to expand patient treatment options.Market Growth ReportsWhat Are the Top 3D Printing Medical Devices Companies in 2026?The global 3D printing medical devices market is valued at USD 2.99 billion in 2026 and is projected to grow to USD 10.11 billion by 2035 at a CAGR of 14.3%, driven by the shift from generic batch-produced medical hardware to patient-specific, anatomically optimized solutions. The article profiles leading companies including Stryker, DePuy Synthes, Zimmer Biomet, Arthrex, Bioretec, GPC Medical, and Merete Medical, detailing their 3D printing capabilities, revenue figures, and 2025 strategic developments. The market's momentum toward mass personalization in orthopedics, dental restorations, and trauma care is expected to propel overall sector value to USD 20.08 billion by 2034.YahooHow the ‘Skubal Scope’ could change pitching injuries — and Tigers ace's seasonDetroit Tigers ace Tarik Skubal became the first known MLB player to undergo a procedure using the NanoNeedle Scope 2.0, a new minimally invasive surgical device made by medical device company Arthrex that removed a loose body from his left elbow in just 32 days compared to the typical 2-3 month recovery for traditional elbow surgery. Dr. Neal ElAttrache, who performed the procedure, said the technology marks a new way to treat one of baseball's most persistent pitching injuries, potentially cutting recovery time in half for similar cases. The innovation, which uses roughly one-seventh the fluid of traditional arthroscopy, could eventually be applied to shoulder injuries, meniscus tears, and other orthopedic procedures beyond sports.Winnipeg Free PressFounder of privately owned medical device giant Arthrex Inc. to receive IDEA honours at Winnipeg gala – Winnipeg Free PressReinhold Schmieding, founder of Arthrex Inc., will receive the IDEA award at a Winnipeg gala on Thursday. Arthrex, a private medical device company, has 15,000 employees and $6 billion in annual revenue. Schmieding said the company will impact over 20 million patients this year.EIN PresswireMeniscus Repair Systems Market worth USD 1,463.18 million by 2032, Exclusive Report by Maximize Market ResearchThe global meniscus repair systems market is projected to grow from USD 832.1 million in 2024 to USD 1,463.18 million by 2032, a CAGR of 7.31%. North America leads, with knee joint repair accounting for over 85% of revenue, and all-inside repair devices expected to grow fastest.openPR.comPlatelet Rich Plasma Market Is Booming Worldwide, Witnessing Strong Growth Through 2033 | Arthrex • Regen Lab • EmCyte CorporationThe article reports on the growth of the Global Platelet Rich Plasma Market from 2026 to 2033, highlighting increased demand and innovation as key drivers. Major companies involved include Arthrex, Regen Lab, and EmCyte Corporation.PRLogSouthwest Florida highlighted as 'global hub for innovation' at 2026 Edison AwardsFive Southwest Florida companies won six awards at the 2026 Edison Awards, including a Gold Edison Award for Fort Myers-based ADDMAN. The event, held April 15-16 in Fort Myers, recognized winners across 50 categories and featured panelists like former Florida Gov. Jeb Bush.openPR.comMedical PRP Tubes Research:CAGR of 5.6% during the forecast periodQY Research Inc. announced the release of a 2025 market report forecasting the global Medical PRP Tubes market to grow from US$ 104 million in 2025 to US$ 159 million by 2032 at a CAGR of 6.3%. The report identifies key industry players including Estar Medical, Regen Lab SA, and Arthrex, noting that the top five manufacturers held approximately 54% of the revenue share in 2024. Growth is driven by increasing procedural volumes in orthopedics, sports medicine, and aesthetics, despite barriers such as inconsistent clinical evidence and reimbursement gaps.FortunebusinessinsightsCartilage Repair Market Size, ShareThe global cartilage repair market was valued at USD 1.58 billion in 2025 and is projected to grow to USD 3.32 billion by 2034, driven by increasing sports injuries, rising osteoarthritis prevalence among aging populations, and advancements in regenerative biologics. North America led the market with a 44.93% share in 2025, while key players including Vericel Corporation, Zimmer Biomet Holdings, Stryker Corporation, Arthrex, Smith & Nephew, Johnson & Johnson, and Anika Therapeutics are driving growth through product innovation and geographic expansion. Recent developments include Anika Therapeutics filing for FDA premarket approval of its Hyalofast scaffold in November 2025 and Vericel Corporation launching its MACI Arthro product in August 2024.TodaysmedicaldevelopmentsArthrex releases all-suture implant for ACL reconstructionArthrex has released the TightRope SB implant, the first all-suture, soft-button technology device on the market for anterior cruciate ligament (ACL) reconstruction, with nearly 2,000 implants already used in procedures across the U.S. The device eliminates rigid materials while providing adjustable fixation, supporting improved knee stability and range of motion without metal implants. The implant won gold at the Edison Awards in April 2025 and was first used in clinical cases by Dr. Rachel M. Frank at CU Anschutz Orthopedics in June 2025.